“April 2017 : Intensification of the Company’s international development with the appointment of a new CEO : Mrs Nawal Ouzren”
“Sensorion aims to become a major player in the development of inner ear disease treatments of and thus fulfill unmet medical needs”
"Our mission is to develop innovative and targeted treatments for inner ear diseases with vertigo, tinnitus, hearing loss"
" Sensorion, has received “French Tech Pass” certification, and thus joins an exclusive circle of innovative French technology companies with substantial development potential"

Contacts

Subscribe

To Sensorion communications

(*) : required field

Civility(*)

Invalid Input

Name(*)
Invalid Input

First name(*)
Invalid Input

Email(*)
Champs invalide

Company
Invalid Input

Sensorion

Laurent Nguyen
Chief Executive Officer
Phone. : +33 4 67 20 77 30
contact@sensorion-pharma.com

 

NewCap

Investor Relations & Strategic communications
Dusan Oresansky / Emmanuel Huynh
Phone. : +33 1 44 71 94 92
sensorion@newcap.eu